Stay updated on bb21217 Efficacy in Myeloma Clinical Trial
Sign up to get notified when there's something new on the bb21217 Efficacy in Myeloma Clinical Trial page.

Latest updates to the bb21217 Efficacy in Myeloma Clinical Trial page
- Check6 days agoChange DetectedAdded a MedlinePlus Genetics related topics: Multiple myeloma resource link to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check13 days agoChange Detected- Removed a MedlinePlus Genetics topic on multiple myeloma, narrowing the page's coverage of genetics resources for this disease.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded MedlinePlus Genetics topic on multiple myeloma to the page, expanding core content related to genetics and disease.SummaryDifference0.3%

- Check28 days agoChange DetectedSignificant additions include a status notice about government funding and operating status, new topic and organization mentions (MedlinePlus Genetics topic: Multiple myeloma; Genetix Biotherapeutics Inc.), and a software revision update (Revision: v3.2.0). The deletions remove bluebird bio and an older revision (v3.1.0). Overall, there is an important update to operating status and new entities/subjects; the removal of a competitor/entity and an older version is also notable.SummaryDifference5%

- Check35 days agoChange DetectedCore terminology updated from Plasma cell myeloma to Multiple myeloma and version bumped to v3.1.0.SummaryDifference0.3%

- Check42 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma, reducing focus on that genetics/resource content. This is a substantive reduction in core topic coverage.SummaryDifference0.3%

Stay in the know with updates to bb21217 Efficacy in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the bb21217 Efficacy in Myeloma Clinical Trial page.